Downregulation of CD94/NKG2A Inhibitory Receptor on Decreased γδ T Cells in Patients with Systemic Lupus Erythematosus

Scandinavian Journal of Immunology

Volumn 76, Issue 1, 2012, Pages 62-69

  Wang, L ^a   Kang, N ^a   Zhou, J ^a   Guo, Y ^b   Zhang, X ^b   Cui, L ^a   Ba, D ^a   He, W ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CD94 ANTIGEN; HLA DR ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2A;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CELL EXPANSION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84862256877     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02705.x     Document Type: Article

References (17)

1. Wohler JE, Smith SS, Barnum SR. gammadelta T cells: the overlooked T-cell subset in demyelinating disease. J Neurosci Res 2010;88:1-6.
2. Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors. Curr Opin Immunol 2006;18:539-46.
3. Morita CT, Beckman EM, Bukowski JF et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 1995;3:495-507.
4. Thedrez A, Sabourin C, Gertner J et al. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 2007;215:123-35.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
6. Martinet L, Fleury-Cappellesso S, Gadelorge M et al. A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells. Eur J Immunol 2009;39:752-62.
7. Ambrus JL, Ambrus JL Jr, Chadha S et al. Mechanism(S) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis. Res Commun Mol Pathol Pharmacol 1997;96:255-65.
8. Patrono C, Ciabattoni G, Remuzzi G et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 1985;76:1011-8.
9. Alaibac M, Berti E, Chizzolini C et al. Role of cellular immunity in the pathogenesis of autoimmune skin diseases. Clin Exp Rheumatol 2006;24:S14-9.
10. Hu M, Chen J, Wang J et al. AFM- and NSOM-based force spectroscopy and distribution analysis of CD69 molecules on human CD4+ T cell membrane. J Mol Recognit 2009;22:516-20.
11. Afeltra A, Galeazzi M, Ferri GM et al. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann Rheum Dis 1993;52:457-60.
12. Takizawa K, Kitani S, Takeuchi F, Yamamoto K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr J 2005;52:635-41.
13. Tsokos GC, Liossis SN. Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 1999;20:119-24.
14. Zhang J, Xiao X, Liu W, Demirci G, Li XC. Inhibitory receptors of the immune system: functions and therapeutic implications. Cell Mol Immunol 2009;6:407-14.
15. Munitz A. Inhibitory receptors on myeloid cells: new targets for therapy? Pharmacol Ther 2010;125:128-37.
16. Halary F, Peyrat MA, Champagne E et al. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997;27:2812-21.
17. Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002;10:147-64.